Mylan, Pfizer Settle Patent Lawsuit With Two Others
BRIEF: Mylan, Pfizer settle patent lawsuit with two others [The Pittsburgh Tribune-Review]
From Pittsburgh Tribune-Review (PA) (February 17, 2012)
Feb. 17--Mylan Inc. said on Thursday that it and Pfizer Inc. had reached a settlement with two companies that want to make a generic version of Mylan's EpiPen.
EpiPen, used to treat severe allergic reactions, is manufactured for Canonsburg-based Mylan by a Pfizer subsidiary, Meridian Medical Technologies. The companies settled a patent infringement lawsuit with Intelliject and Sanofi-Aventis over Intelliject's e-cue product, which is an epinephrine auto-injector like EpiPen, Mylan said.
Under the settlement, Intelliject's e-cue, which will be manufactured and sold by Sanofi-Aventis, may not be introduced on the U.S. market before Nov. 15, pending approval by the Food and Drug Administration.
___
(c)2012 The Pittsburgh Tribune-Review (Greensburg, Pa.)
Visit The Pittsburgh Tribune-Review (Greensburg, Pa.) at www.pittsburghlive.com/x/pittsburghtrib
Distributed by MCT Information Services
Posted: February 2012
